WADA 2026 Prohibited List Status (Section S0) BPC-157 is named explicitly on the World Anti-Doping Agency 2025 and 2026 Prohibited Lists under section S0 (Non-Approved Substances)
The product is not intended for human consumption, animal use, diagnosis, treatment, prevention, or personal experimentation
doi:10.2147/OPTH.S80954
Upon entry into the parenchyma, these cells initiate a secondary immune response, releasing inflammatory mediators such as cytokines, chemokines, proteases, and toxic substances, aggravating myelin and axonal damage [263]
What it is: A 15-amino-acid synthetic peptide sharing the BPC-157 sequence (GEPPPGKPADDAGLV), marketed with an arginine salt counterion rather than an acetate salt